Sygehus Lillebaelt - Vejle Sygehus

Vejle 7100

1 studies enrolling now · 2 studies all time

What they study most

Advanced Non-Small Cell Lung Cancer, HER2 Positive Breast Cancer, Metastatic Non-Small Cell Lung Cancer

Studies at this site

• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
• A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer — Completed